Drug profile · INN
dornase alfa
PULMOZYME
dornase alfa (PULMOZYME) is a dna hydrolytic enzyme. Associated with Hoffmann-La Roche. Current US regulatory status: approved.
Drug details — dornase alfa
- US status
- approved
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.81
Quick answer
dornase alfa (PULMOZYME) is a dna hydrolytic enzyme. Associated with Hoffmann-La Roche. Current US regulatory status: approved.
Key facts
Mechanism of action
DNA hydrolytic enzyme
Primary target: DNA
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
Related & competitor drugs
Frequently asked questions
What is dornase alfa?
dornase alfa (PULMOZYME) is a dna hydrolytic enzyme. Associated with Hoffmann-La Roche. Current US regulatory status: approved.
What is the brand name for dornase alfa?
PULMOZYME is a marketed brand name for dornase alfa. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of dornase alfa?
dornase alfa has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.